Retatrutide (Triple Agonist) Program

What Is Retatrutide?

Retatrutide is a next-generation triple receptor agonist that simultaneously activates three distinct hormonal pathways involved in appetite regulation, metabolic efficiency, and energy expenditure: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-agonist mechanism — abbreviated GLP-1/GIP/GCG agonism — represents a fundamentally more comprehensive engagement of the metabolic regulatory system than either semaglutide (single GLP-1 agonist) or tirzepatide (dual GLP-1/GIP agonist) can achieve. The critical addition of glucagon receptor agonism is what sets retatrutide apart. Glucagon is a hormone that, when activated at the receptor level in the liver and adipose tissue, significantly increases energy expenditure, stimulates fat mobilization and oxidation, and reduces liver fat — effects that neither GLP-1 nor GIP agonism produce at equivalent magnitude. By combining glucagon agonism with the powerful appetite suppression and insulin-sensitizing effects of GLP-1/GIP activation, retatrutide produces a uniquely comprehensive metabolic intervention that addresses all three primary drivers of excess weight: excessive appetite, insufficient satiety, and reduced energy expenditure. In Phase 2 clinical trials published in the New England Journal of Medicine, retatrutide produced average weight reductions of 17.5% at 24 weeks and 24.2% of body weight at 48 weeks at the highest dose studied — the highest weight loss efficacy ever documented for a pharmacological agent in a clinical trial at the time of publication.

How Retatrutide’s Triple-Agonist Mechanism Works

To understand why retatrutide produces greater weight loss than its predecessors, it helps to understand what each receptor pathway contributes. GLP-1 receptor activation reduces appetite by acting on hypothalamic hunger circuits, slows gastric emptying to prolong satiety, and improves glucose-stimulated insulin secretion. GIP receptor activation enhances adipocyte insulin sensitivity, promotes fat mobilization, and complements GLP-1’s appetite and insulin effects through synergistic receptor cross-talk. Glucagon receptor activation increases hepatic glucose production (which is tightly regulated), dramatically increases basal energy expenditure — essentially raising the metabolic rate — stimulates lipolysis and fatty acid oxidation in adipose tissue, and significantly reduces hepatic fat content (liver fat), which is an important metabolic driver of insulin resistance and obesity. The combination of all three mechanisms creates a metabolic environment in which appetite is powerfully suppressed, satiety is substantially enhanced, insulin sensitivity is maximized, fat burning is actively stimulated, and the overall energy balance equation is shifted in the direction of weight loss with a comprehensiveness that single or dual-agonist approaches cannot match.

Who Is the Best Candidate for the Retatrutide Program?

The Retatrutide program at Hawaii Wellness Clinic is designed for patients who require the most advanced level of pharmacological metabolic support available. It is particularly well suited for patients with a BMI of 35 or greater, or significant obesity-related metabolic conditions including type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), or severe insulin resistance, who have tried semaglutide or tirzepatide without achieving adequate weight loss results, who have significant metabolic resistance — meaning their physiology actively resists weight loss through compensatory hormonal mechanisms, who need the most potent available tool for weight reduction alongside lifestyle changes and medical supervision, or who are seeking to avoid bariatric surgery but need a comparable level of intervention. Eligibility is assessed through a comprehensive physician consultation that includes your complete medical history, metabolic lab work, medication list, and an honest discussion of your treatment goals and expectations.

Our Retatrutide Program Structure

At Hawaii Wellness Clinic in , your Retatrutide program begins with a thorough medical consultation during which your physician reviews your metabolic health, weight history, previous weight loss treatments, and goals. Your personalized dosing protocol is developed based on your clinical profile, with careful dose escalation designed to maximize therapeutic benefit while minimizing side effects. Retatrutide is administered as a once-weekly subcutaneous injection. Regular physician follow-up appointments throughout the program provide progress monitoring, dosage adjustments, side effect management, and ongoing nutritional and lifestyle guidance. As with our other weight loss programs, Retatrutide treatment integrates seamlessly with supportive services including Hormone Replacement Therapy, Peptide Therapy, and IV Vitamin Therapy for patients with additional contributing factors to their weight challenges.

Retatrutide Side Effects and Safety

Based on Phase 2 clinical trial data, retatrutide shares a side effect profile broadly similar to other GLP-1 class medications — with gastrointestinal effects (nausea, diarrhea, constipation, vomiting) being the most commonly reported, primarily during dose escalation and typically transient. The glucagon component may also cause mild elevations in heart rate in some patients, which is monitored throughout the program. As with all GLP-1 class medications, retatrutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, and is not appropriate for patients with a history of pancreatitis. All relevant contraindications are assessed during your pre-treatment evaluation.

Why Choose Hawaii Wellness Clinic for Retatrutide Treatment?

At Hawaii Wellness Clinic in , we are proud to offer the most advanced medical weight loss options available — including retatrutide — within the context of rigorous physician supervision, genuine personalization, and compassionate, judgment-free care. Our physicians stay at the forefront of metabolic medicine to ensure our patients have access to the latest and most effective treatments as they emerge. Our aloha-inspired clinics across O’ahu, Hawai’i Island, and Maui make cutting-edge weight loss care accessible throughout Hawaii. To find out whether the Retatrutide program is the right choice for you, call us at (808) 201-2343 - Honolulu Office , (808) 201-2343 - Kailua Kona Office or (808) 201-2343 - Hilo Office today. You can also review our full Medical Weight Loss Overview or compare options with our Semaglutide and Tirzepatide programs.

Frequently Asked Questions About the Retatrutide Triple Agonist Program in Hawaii